Table 3. Association of PCSK9 loss-of-function variants and risk of serious infection and sepsis hospitalizations.
Serious Infection Hospitalizations (N = 10,924) |
No. Events | No. Non-Events |
Events Per 1,000 Person-Years (95%CI) |
Crude HR (95% CI) |
Model 1 HR (95% CI) |
Model 2 HR (95% CI) |
Model 3 HR (95% CI) |
PCSK9 variant present | 14 (5.7%) | 230 (94.3%) | 9.8 (5.8–16.5) | 0.82 (0.48–1.40) | 0.84 (0.49–1.42) | 0.68 (0.38–1.25) | 0.83 (0.49–1.40) |
PCSK9 variant absent | 765 (7.2%) | 9,915 (92.8%) | 11.9 (11.1–12.8) | Ref. | Ref. | Ref. | Ref. |
Total | 779 (7.1%) | 10,145 (92.9%) | 11.9 (11.1–12.7) | - | - | - | - |
Sepsis Within Serious Infection Hospitalizations (N = 779) |
No. Events | No. Non-events |
Events Per 1,000 Person-Years (95%CI) |
Crude OR (95% CI) |
Model 1 OR (95% CI) |
Model 2 OR (95% CI) |
Model 3 OR (95% CI) |
PCSK9 variant present | 11 (2.5%) | 3 (0.9%) | N/A | 3.28 (0.91–11.84) | 3.34 (0.91–12.19) | 7.31 (0.91–58.7) | 3.22 (0.89–11.6) |
PCSK9 variant absent | 404 (97.4%) | 361 (99.2%) | N/A | Ref. | Ref. | Ref. | Ref. |
Total | 415 (53.3%) | 364 (46.7%) | N/A | - | - | - | - |
Model 1. Adjusted for demographics, smoking, and alcohol use
Model 2. Adjusted for model 1 + comorbidities + biomarkers
Model 3. Adjusted for sepsis risk score categories